- Home
- VREX vs SANA Comparison
VREX vs SANA Comparison
Compare VREX & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VREX
- SANA
- Stock Information
- Founded
- VREX 2016
- SANA 2018
- Country
- VREX United States
- SANA United States
- Employees
- VREX N/A
- SANA N/A
- Industry
- VREX Industrial Machinery/Components
- SANA Medicinal Chemicals and Botanical Products
- Sector
- VREX Technology
- SANA Health Care
- Exchange
- VREX Nasdaq
- SANA Nasdaq
- Market Cap
- VREX 576.8M
- SANA 519.8M
- IPO Year
- VREX N/A
- SANA 2021
- Fundamental
- Price
- VREX $11.68
- SANA $1.71
- Analyst Decision
- VREX Strong Buy
- SANA Strong Buy
- Analyst Count
- VREX 2
- SANA 5
- Target Price
- VREX $22.50
- SANA $9.50
- AVG Volume (30 Days)
- VREX 326.9K
- SANA 3.6M
- Earning Date
- VREX 05-01-2025
- SANA 03-17-2025
- Dividend Yield
- VREX N/A
- SANA N/A
- EPS Growth
- VREX N/A
- SANA N/A
- EPS
- VREX N/A
- SANA N/A
- Revenue
- VREX $820,800,000.00
- SANA N/A
- Revenue This Year
- VREX $4.03
- SANA N/A
- Revenue Next Year
- VREX $3.32
- SANA N/A
- P/E Ratio
- VREX N/A
- SANA N/A
- Revenue Growth
- VREX N/A
- SANA N/A
- 52 Week Low
- VREX $10.19
- SANA $1.52
- 52 Week High
- VREX $18.30
- SANA $10.50
- Technical
- Relative Strength Index (RSI)
- VREX 33.80
- SANA 30.21
- Support Level
- VREX $12.40
- SANA $2.18
- Resistance Level
- VREX $12.78
- SANA $2.43
- Average True Range (ATR)
- VREX 0.43
- SANA 0.27
- MACD
- VREX -0.08
- SANA -0.09
- Stochastic Oscillator
- VREX 20.67
- SANA 3.07
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.